Is there a rationale in modulating brainstem neurons in obstructive sleep apnea and is it clinically relevant?
Horner
R L
RL
Department of Medicine, University of Toronto, Ontario, Canada. richard.horner@utoronto.ca
D001933:Brain Stem / Q000378:metabolism*; D002799:Cholinergic Fibers / Q000378:metabolism; D005998:Glycine / Q000378:metabolism; D006801:Humans; D007002:Hypoglossal Nerve / Q000378:metabolism; D009474:Neurons / Q000378:metabolism*; D009638:Norepinephrine / Q000378:metabolism; D010609:Pharyngeal Muscles / Q000378:metabolism; D011149:Pons / Q000378:metabolism; D012701:Serotonin / Q000378:metabolism; D020181:Sleep Apnea, Obstructive / Q000503:physiopathology* / Q000628:therapy; D012895:Sleep, REM / Q000502:physiology; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
D012701:Serotonin; D005680:gamma-Aminobutyric Acid; D005998:Glycine; D009638:Norepinephrine